Goldman Sachs’s Salarius Pharmaceuticals SLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.9K Buy
+1,111
New +$14.9K ﹤0.01% 5064
2017
Q3
Hold
0
-$87K 4395
2017
Q2
Hold
0
-$46K 4165
2017
Q1
Hold
0
-$90K 4228
2016
Q4
Hold
0
4124
2016
Q3
Hold
0
-$131K 4634
2016
Q2
Hold
0
-$263K 4030
2016
Q1
Hold
0
-$193K 3617
2015
Q4
Hold
0
3757